#FORMAT=WebAnno TSV 3.3
#T_SP=webanno.custom.ConceptLayer|identifier


1-1	0-8	NICOTINE	_
1-2	9-19	ABSTINENCE	http://maven.renci.org/NeuroBridge/neurobridge#Abstinent
1-3	20-30	INFLUENCES	_
1-4	31-34	THE	_
1-5	35-46	CALCULATION	_
1-6	47-49	OF	_
1-7	50-58	SALIENCE	_
1-8	59-61	IN	_
1-9	62-70	DISCRETE	_
1-10	71-78	INSULAR	http://maven.renci.org/NeuroBridge/neurobridge#Insulin
1-11	79-87	CIRCUITS	_
1-12	88-98	Background	_
1-13	99-106	Insular	_
1-14	107-119	subdivisions	_
1-15	120-124	show	_
1-16	125-133	distinct	_
1-17	134-142	patterns	_
1-18	143-145	of	_
1-19	146-153	resting	http://maven.renci.org/NeuroBridge/neurobridge#RestingStateImaging
1-20	154-159	state	http://maven.renci.org/NeuroBridge/neurobridge#RestingStateImaging
1-21	160-170	functional	_
1-22	171-183	connectivity	_
1-23	184-185	(	_
1-24	186-190	rsFC	_
1-25	191-192	)	_
1-26	193-197	with	_
1-27	198-206	specific	_
1-28	207-212	brain	_
1-29	213-220	regions	_
1-30	221-222	,	_
1-31	223-227	each	_
1-32	228-232	with	_
1-33	233-242	different	_
1-34	243-253	functional	_
1-35	254-266	significance	_
1-36	267-268	.	_

2-1	269-274	Seeds	_
2-2	275-277	in	_
2-3	278-283	these	_
2-4	284-296	subdivisions	_
2-5	297-300	are	_
2-6	301-309	employed	_
2-7	310-312	to	_
2-8	313-325	characterize	_
2-9	326-329	the	_
2-10	330-337	effects	_
2-11	338-340	of	_
2-12	341-346	acute	_
2-13	347-355	nicotine	_
2-14	356-366	abstinence	_
2-15	367-369	on	_
2-16	370-374	rsFC	_
2-17	375-382	between	_
2-18	383-389	insula	_
2-19	390-402	subdivisions	_
2-20	403-406	and	_
2-21	407-412	brain	_
2-22	413-421	networks	_
2-23	422-432	implicated	_
2-24	433-435	in	_
2-25	436-445	addiction	_
2-26	446-449	and	_
2-27	450-461	attentional	_
2-28	462-469	control	_
2-29	470-471	.	_

3-1	472-479	Methods	_
3-2	480-482	In	_
3-3	483-484	a	_
3-4	485-491	within	_
3-5	492-500	subjects	_
3-6	501-507	design	_
3-7	508-509	,	_
3-8	510-523	resting-state	http://maven.renci.org/NeuroBridge/neurobridge#RestingStateImaging
3-9	524-528	BOLD	http://maven.renci.org/NeuroBridge/neurobridge#RestingStateImaging
3-10	529-533	data	_
3-11	534-538	were	_
3-12	539-548	collected	_
3-13	549-553	from	_
3-14	554-571	treatment-seeking	_
3-15	572-579	smokers	http://maven.renci.org/NeuroBridge/neurobridge#Person
3-16	580-581	(	_
3-17	582-586	n=20	_
3-18	587-588	)	_
3-19	589-598	following	_
3-20	599-606	smoking	_
3-21	607-614	satiety	_
3-22	615-618	and	_
3-23	619-624	again	_
3-24	625-634	following	_
3-25	635-637	48	_
3-26	638-643	hours	_
3-27	644-646	of	_
3-28	647-655	nicotine	_
3-29	656-666	abstinence	_
3-30	667-668	.	_

4-1	669-674	Three	_
4-2	675-680	right	_
4-3	681-691	hemisphere	_
4-4	692-699	insular	_
4-5	700-707	regions	_
4-6	708-710	of	_
4-7	711-719	interest	_
4-8	720-721	(	_
4-9	722-728	dorsal	_
4-10	729-730	,	_
4-11	731-738	ventral	_
4-12	739-740	,	_
4-13	741-744	and	_
4-14	745-754	posterior	_
4-15	755-756	)	_
4-16	757-763	served	_
4-17	764-766	as	_
4-18	767-772	seeds	_
4-19	773-776	for	_
4-20	777-785	analyses	_
4-21	786-787	.	_

5-1	788-795	Indices	_
5-2	796-798	of	_
5-3	799-803	both	_
5-4	804-810	static	_
5-5	811-814	and	_
5-6	815-822	dynamic	_
5-7	823-827	rsFC	_
5-8	828-832	were	_
5-9	833-841	obtained	_
5-10	842-845	and	_
5-11	846-856	correlated	_
5-12	857-861	with	_
5-13	862-869	indices	_
5-14	870-872	of	_
5-15	873-883	subjective	_
5-16	884-894	withdrawal	_
5-17	895-898	and	_
5-18	899-909	behavioral	_
5-19	910-921	performance	_
5-20	922-923	.	_

6-1	924-931	Results	_
6-2	932-950	Abstinence-induced	_
6-3	951-964	physiological	_
6-4	965-966	,	_
6-5	967-977	subjective	_
6-6	978-979	,	_
6-7	980-983	and	_
6-8	984-993	cognitive	_
6-9	994-1005	differences	_
6-10	1006-1010	were	_
6-11	1011-1019	observed	_
6-12	1020-1021	.	_

7-1	1022-1029	Overall	_
7-2	1030-1037	dynamic	_
7-3	1038-1042	rsFC	_
7-4	1043-1046	was	_
7-5	1047-1054	reduced	_
7-6	1055-1061	during	_
7-7	1062-1072	abstinence	_
7-8	1073-1074	,	_
7-9	1075-1078	and	_
7-10	1079-1087	circuits	_
7-11	1088-1098	containing	_
7-12	1099-1103	each	_
7-13	1104-1111	insular	_
7-14	1112-1116	seed	_
7-15	1117-1123	showed	_
7-16	1124-1131	changes	_
7-17	1132-1134	in	_
7-18	1135-1139	rsFC	_
7-19	1140-1142	as	_
7-20	1143-1144	a	_
7-21	1145-1153	function	_
7-22	1154-1156	of	_
7-23	1157-1165	nicotine	_
7-24	1166-1176	abstinence	_
7-25	1177-1178	.	_

8-1	1179-1191	Specifically	_
8-2	1192-1193	,	_
8-3	1194-1200	dorsal	_
8-4	1201-1204	and	_
8-5	1205-1214	posterior	_
8-6	1215-1222	insular	_
8-7	1223-1234	connections	_
8-8	1235-1237	to	_
8-9	1238-1241	the	_
8-10	1242-1249	default	_
8-11	1250-1254	mode	_
8-12	1255-1258	and	_
8-13	1259-1267	salience	_
8-14	1268-1276	networks	_
8-15	1277-1281	were	_
8-16	1282-1290	enhanced	_
8-17	1291-1292	,	_
8-18	1293-1298	while	_
8-19	1299-1300	a	_
8-20	1301-1311	previously	_
8-21	1312-1323	undescribed	_
8-22	1324-1331	ventral	_
8-23	1332-1339	insular	_
8-24	1340-1350	connection	_
8-25	1351-1353	to	_
8-26	1354-1357	the	_
8-27	1358-1367	executive	_
8-28	1368-1375	control	_
8-29	1376-1383	network	_
8-30	1384-1387	was	_
8-31	1388-1395	reduced	_
8-32	1396-1397	.	_

9-1	1398-1405	Further	_
9-2	1406-1407	,	_
9-3	1408-1414	static	_
9-4	1415-1419	rsFC	_
9-5	1420-1423	was	_
9-6	1424-1437	significantly	_
9-7	1438-1448	correlated	_
9-8	1449-1453	with	_
9-9	1454-1464	subjective	_
9-10	1465-1472	ratings	_
9-11	1473-1475	of	_
9-12	1476-1484	aversive	_
9-13	1485-1491	affect	_
9-14	1492-1495	and	_
9-15	1496-1506	withdrawal	_
9-16	1507-1509	in	_
9-17	1510-1513	the	_
9-18	1514-1522	modified	_
9-19	1523-1530	ventral	_
9-20	1531-1534	and	_
9-21	1535-1544	posterior	_
9-22	1545-1559	insular-seeded	_
9-23	1560-1568	circuits	_
9-24	1569-1570	.	_

10-1	1571-1582	Conclusions	_
10-2	1583-1585	As	_
10-3	1586-1595	predicted	_
10-4	1596-1597	,	_
10-5	1598-1607	divergent	_
10-6	1608-1619	connections	_
10-7	1620-1627	between	_
10-8	1628-1634	insula	_
10-9	1635-1647	subdivisions	_
10-10	1648-1651	and	_
10-11	1652-1666	anticorrelated	_
10-12	1667-1674	resting	_
10-13	1675-1680	brain	_
10-14	1681-1689	networks	_
10-15	1690-1694	were	_
10-16	1695-1703	observed	_
10-17	1704-1710	during	_
10-18	1711-1721	abstinence	_
10-19	1722-1723	.	_

11-1	1724-1729	These	_
11-2	1730-1737	changes	_
11-3	1738-1745	reflect	_
11-4	1746-1748	an	_
11-5	1749-1760	attentional	_
11-6	1761-1765	bias	_
11-7	1766-1772	toward	_
11-8	1773-1781	aversive	_
11-9	1782-1791	affective	_
11-10	1792-1802	processing	_
11-11	1803-1806	and	_
11-12	1807-1810	not	_
11-13	1811-1819	directly	_
11-14	1820-1824	away	_
11-15	1825-1829	from	_
11-16	1830-1839	exogenous	_
11-17	1840-1849	cognitive	_
11-18	1850-1860	processing	_
11-19	1861-1862	,	_
11-20	1863-1873	suggesting	_
11-21	1874-1875	a	_
11-22	1876-1887	coordinated	_
11-23	1888-1898	modulation	_
11-24	1899-1901	of	_
11-25	1902-1910	circuits	_
11-26	1911-1921	associated	_
11-27	1922-1926	with	_
11-28	1927-1940	interoceptive	_
11-29	1941-1944	and	_
11-30	1945-1954	affective	_
11-31	1955-1965	processing	_
11-32	1966-1970	that	_
11-33	1971-1983	instantiates	_
11-34	1984-1986	an	_
11-35	1987-1995	aversive	_
11-36	1996-2001	state	_
11-37	2002-2008	during	_
11-38	2009-2017	nicotine	_
11-39	2018-2028	abstinence	_
11-40	2029-2030	.	_

12-1	2031-2038	METHODS	http://maven.renci.org/NeuroBridge/neurobridge#DataCollectionMethod
12-2	2039-2051	Participants	_
12-3	2052-2058	Twenty	_
12-4	2059-2066	smoking	_
12-5	2067-2076	cessation	_
12-6	2077-2094	treatment-seeking	_
12-7	2095-2107	participants	_
12-8	2108-2117	completed	_
12-9	2118-2121	all	_
12-10	2122-2134	experimental	_
12-11	2135-2145	procedures	_
12-12	2146-2147	.	_

13-1	2148-2160	Participants	_
13-2	2161-2165	were	_
13-3	2166-2174	required	_
13-4	2175-2177	to	_
13-5	2178-2180	be	_
13-6	2181-2193	right-handed	_
13-7	2194-2195	,	_
13-8	2196-2201	18–60	_
13-9	2202-2207	years	_
13-10	2208-2210	of	_
13-11	2211-2214	age	_
13-12	2215-2216	,	_
13-13	2217-2221	free	_
13-14	2222-2224	of	_
13-15	2225-2231	active	_
13-16	2232-2236	drug	_
13-17	2237-2239	or	_
13-18	2240-2247	alcohol	_
13-19	2248-2264	abuse/dependence	_
13-20	2265-2266	(	_
13-21	2267-2272	other	_
13-22	2273-2277	than	_
13-23	2278-2286	nicotine	_
13-24	2287-2288	)	_
13-25	2289-2290	,	_
13-26	2291-2297	report	_
13-27	2298-2300	no	_
13-28	2301-2308	current	_
13-29	2309-2320	psychiatric	_
13-30	2321-2323	or	_
13-31	2324-2336	neurological	_
13-32	2337-2346	disorders	_
13-33	2347-2348	,	_
13-34	2349-2352	and	_
13-35	2353-2357	have	_
13-36	2358-2360	no	_
13-37	2361-2378	contraindications	_
13-38	2379-2382	for	_
13-39	2383-2391	magnetic	http://maven.renci.org/NeuroBridge/neurobridge#MagneticResonanceImaging
13-40	2392-2401	resonance	http://maven.renci.org/NeuroBridge/neurobridge#MagneticResonanceImaging
13-41	2402-2409	imaging	http://maven.renci.org/NeuroBridge/neurobridge#MagneticResonanceImaging
13-42	2410-2411	(	http://maven.renci.org/NeuroBridge/neurobridge#MagneticResonanceImaging
13-43	2412-2415	MRI	http://maven.renci.org/NeuroBridge/neurobridge#MagneticResonanceImaging
13-44	2416-2417	)	http://maven.renci.org/NeuroBridge/neurobridge#MagneticResonanceImaging
13-45	2418-2419	(	_
13-46	2420-2425	Table	_
13-47	2426-2427	1	_
13-48	2428-2429	)	_
13-49	2430-2431	.	_

14-1	2432-2439	Written	_
14-2	2440-2448	informed	_
14-3	2449-2456	consent	_
14-4	2457-2460	was	_
14-5	2461-2469	obtained	_
14-6	2470-2472	in	_
14-7	2473-2483	accordance	_
14-8	2484-2488	with	_
14-9	2489-2492	the	_
14-10	2493-2501	NIDA-IRP	_
14-11	2502-2515	Institutional	_
14-12	2516-2522	Review	_
14-13	2523-2528	Board	_
14-14	2529-2530	.	_

15-1	2531-2543	Experimental	_
15-2	2544-2550	Design	_
15-3	2551-2553	In	_
15-4	2554-2558	this	_
15-5	2559-2571	longitudinal	_
15-6	2572-2573	,	_
15-7	2574-2589	within-subjects	_
15-8	2590-2596	design	_
15-9	2597-2598	,	_
15-10	2599-2603	each	_
15-11	2604-2615	participant	_
15-12	2616-2625	completed	_
15-13	2626-2629	two	_
15-14	2630-2632	MR	http://maven.renci.org/NeuroBridge/neurobridge#MagneticResonanceImaging
15-15	2633-2641	scanning	http://maven.renci.org/NeuroBridge/neurobridge#MagneticResonanceImaging
15-16	2642-2650	sessions	http://maven.renci.org/NeuroBridge/neurobridge#MagneticResonanceImaging
15-17	2651-2652	,	_
15-18	2653-2656	one	_
15-19	2657-2663	during	_
15-20	2664-2666	ad	_
15-21	2667-2670	lib	_
15-22	2671-2676	sated	_
15-23	2677-2684	smoking	_
15-24	2685-2686	,	_
15-25	2687-2695	followed	_
15-26	2696-2698	by	_
15-27	2699-2701	an	_
15-28	2702-2707	acute	http://maven.renci.org/NeuroBridge/neurobridge#ComputedTomographyScan
15-29	2708-2718	abstinence	http://maven.renci.org/NeuroBridge/neurobridge#ComputedTomographyScan
15-30	2719-2723	scan	http://maven.renci.org/NeuroBridge/neurobridge#ComputedTomographyScan
15-31	2724-2728	with	_
15-32	2729-2733	last	_
15-33	2734-2743	cigarette	_
15-34	2744-2747	~48	_
15-35	2748-2753	hours	_
15-36	2754-2759	prior	_
15-37	2760-2762	to	_
15-38	2763-2767	scan	_
15-39	2768-2769	.	_

16-1	2770-2772	As	_
16-2	2773-2785	participants	_
16-3	2786-2790	were	_
16-4	2791-2799	enrolled	_
16-5	2800-2802	in	_
16-6	2803-2804	a	_
16-7	2805-2812	smoking	_
16-8	2813-2822	cessation	_
16-9	2823-2831	protocol	_
16-10	2832-2833	,	_
16-11	2834-2837	the	_
16-12	2838-2843	order	_
16-13	2844-2846	of	_
16-14	2847-2850	the	_
16-15	2851-2854	two	_
16-16	2855-2860	scans	_
16-17	2861-2864	was	_
16-18	2865-2870	fixed	_
16-19	2871-2872	,	_
16-20	2873-2877	with	_
16-21	2878-2881	the	_
16-22	2882-2887	sated	_
16-23	2888-2892	scan	_
16-24	2893-2902	preceding	_
16-25	2903-2906	the	_
16-26	2907-2916	abstinent	_
16-27	2917-2921	scan	_
16-28	2922-2924	by	_
16-29	2925-2927	an	_
16-30	2928-2935	average	_
16-31	2936-2938	of	_
16-32	2939-2941	67	_
16-33	2942-2946	days	_
16-34	2947-2948	(	_
16-35	2949-2955	median	_
16-36	2956-2958	28	_
16-37	2959-2963	days	_
16-38	2964-2965	)	_
16-39	2966-2967	.	_

17-1	2968-2969	(	_
17-2	2970-2973	See	_
17-3	2974-2984	supplement	_
17-4	2985-2988	for	_
17-5	2989-2996	general	_
17-6	2997-3007	procedures	_
17-7	3008-3009	)	_
17-8	3010-3020	Behavioral	_
17-9	3021-3025	task	http://maven.renci.org/NeuroBridge/neurobridge#BackTaskTest
17-10	3026-3033	measure	http://maven.renci.org/NeuroBridge/neurobridge#BackTaskTest
17-11	3034-3043	Following	_
17-12	3044-3049	brief	_
17-13	3050-3057	medical	_
17-14	3058-3068	assessment	_
17-15	3069-3070	,	_
17-16	3071-3083	participants	_
17-17	3084-3093	completed	_
17-18	3094-3095	a	_
17-19	3096-3105	12-minute	_
17-20	3106-3111	rapid	http://maven.renci.org/NeuroBridge/neurobridge#AffectiveProcessingScale
17-21	3112-3118	visual	http://maven.renci.org/NeuroBridge/neurobridge#AffectiveProcessingScale
17-22	3119-3130	information	http://maven.renci.org/NeuroBridge/neurobridge#AffectiveProcessingScale
17-23	3131-3141	processing	http://maven.renci.org/NeuroBridge/neurobridge#AffectiveProcessingScale
17-24	3142-3143	(	http://maven.renci.org/NeuroBridge/neurobridge#AffectiveProcessingScale
17-25	3144-3148	RVIP	http://maven.renci.org/NeuroBridge/neurobridge#AffectiveProcessingScale
17-26	3149-3150	)	http://maven.renci.org/NeuroBridge/neurobridge#AffectiveProcessingScale
17-27	3151-3155	task	http://maven.renci.org/NeuroBridge/neurobridge#AffectiveProcessingScale
17-28	3156-3168	administered	_
17-29	3169-3171	at	_
17-30	3172-3173	a	_
17-31	3174-3182	computer	_
17-32	3183-3190	outside	_
17-33	3191-3194	the	_
17-34	3195-3198	MRI	http://maven.renci.org/NeuroBridge/neurobridge#MagneticResonanceImaging
17-35	3199-3206	scanner	_
17-36	3207-3209	to	_
17-37	3210-3216	assess	_
17-38	3217-3226	sustained	_
17-39	3227-3236	attention	_
17-40	3237-3247	processing	_
17-41	3248-3249	(	_
17-42	3250-3253	See	_
17-43	3254-3264	supplement	_
17-44	3265-3268	for	_
17-45	3269-3273	task	_
17-46	3274-3281	details	_
17-47	3282-3283	)	_
17-48	3284-3285	.	_

18-1	3286-3296	Subjective	_
18-2	3297-3307	withdrawal	_
18-3	3308-3315	measure	_
18-4	3316-3324	Directly	_
18-5	3325-3331	before	_
18-6	3332-3336	each	_
18-7	3337-3345	scanning	_
18-8	3346-3353	session	_
18-9	3354-3355	(	_
18-10	3356-3361	sated	_
18-11	3362-3365	and	_
18-12	3366-3375	abstinent	_
18-13	3376-3377	)	_
18-14	3378-3379	,	_
18-15	3380-3390	subjective	_
18-16	3391-3398	ratings	_
18-17	3399-3401	of	_
18-18	3402-3420	withdrawal-related	_
18-19	3421-3429	symptoms	_
18-20	3430-3434	were	_
18-21	3435-3443	assessed	_
18-22	3444-3447	via	_
18-23	3448-3451	the	_
18-24	3452-3461	Wisconsin	http://maven.renci.org/NeuroBridge/neurobridge#WisconsinSmokingWithdrawalScale
18-25	3462-3469	Smoking	http://maven.renci.org/NeuroBridge/neurobridge#WisconsinSmokingWithdrawalScale
18-26	3470-3480	Withdrawal	http://maven.renci.org/NeuroBridge/neurobridge#WisconsinSmokingWithdrawalScale
18-27	3481-3486	Scale	http://maven.renci.org/NeuroBridge/neurobridge#WisconsinSmokingWithdrawalScale
18-28	3487-3488	(	http://maven.renci.org/NeuroBridge/neurobridge#WisconsinSmokingWithdrawalScale
18-29	3489-3493	WSWS	http://maven.renci.org/NeuroBridge/neurobridge#WisconsinSmokingWithdrawalScale
18-30	3494-3495	)	http://maven.renci.org/NeuroBridge/neurobridge#WisconsinSmokingWithdrawalScale
18-31	3496-3497	,	_
18-32	3498-3499	a	_
18-33	3500-3502	28	_
18-34	3503-3507	item	_
18-35	3508-3519	self-report	_
18-36	3520-3524	test	_
18-37	3525-3534	comprised	_
18-38	3535-3537	of	_
18-39	3538-3539	7	_
18-40	3540-3549	subscales	_
18-41	3550-3551	(	_
18-42	3552-3557	Anger	_
18-43	3558-3559	,	_
18-44	3560-3567	Anxiety	_
18-45	3568-3569	,	_
18-46	3570-3583	Concentration	_
18-47	3584-3585	,	_
18-48	3586-3593	Craving	_
18-49	3594-3595	,	_
18-50	3596-3602	Hunger	_
18-51	3603-3604	,	_
18-52	3605-3612	Sadness	_
18-53	3613-3614	,	_
18-54	3615-3620	Sleep	_
18-55	3621-3622	)	_
18-56	3623-3624	,	_
18-57	3625-3628	and	_
18-58	3629-3634	TOTAL	_
18-59	3635-3640	score	_
18-60	3641-3642	.	_

19-1	3643-3645	As	_
19-2	3646-3654	pre-scan	_
19-3	3655-3665	procedures	_
19-4	3666-3675	generally	_
19-5	3676-3680	took	_
19-6	3681-3683	up	_
19-7	3684-3686	to	_
19-8	3687-3690	120	_
19-9	3691-3694	min	_
19-10	3695-3696	,	_
19-11	3697-3709	participants	_
19-12	3710-3714	were	_
19-13	3715-3720	given	_
19-14	3721-3722	a	_
19-15	3723-3724	<	_
19-16	3725-3727	10	_
19-17	3728-3731	min	_
19-18	3732-3739	smoking	_
19-19	3740-3745	break	_
19-20	3746-3757	immediately	_
19-21	3758-3763	prior	_
19-22	3764-3766	to	_
19-23	3767-3770	the	_
19-24	3771-3781	withdrawal	_
19-25	3782-3792	assessment	_
19-26	3793-3796	and	_
19-27	3797-3800	MRI	http://maven.renci.org/NeuroBridge/neurobridge#MagneticResonanceImagingInstrument
19-28	3801-3805	scan	http://maven.renci.org/NeuroBridge/neurobridge#MagneticResonanceImagingInstrument
19-29	3806-3812	during	_
19-30	3813-3816	the	_
19-31	3817-3822	sated	_
19-32	3823-3827	scan	_
19-33	3828-3835	session	_
19-34	3836-3840	only	_
19-35	3841-3842	.	_

20-1	3843-3846	MRI	http://maven.renci.org/NeuroBridge/neurobridge#MagneticResonanceImaging
20-2	3847-3855	Scanning	http://maven.renci.org/NeuroBridge/neurobridge#MagneticResonanceImaging
20-3	3856-3865	Following	_
20-4	3866-3870	WSWS	http://maven.renci.org/NeuroBridge/neurobridge#WisconsinSmokingWithdrawalScale
20-5	3871-3885	administration	_
20-6	3886-3887	,	_
20-7	3888-3900	participants	_
20-8	3901-3912	immediately	_
20-9	3913-3920	entered	_
20-10	3921-3924	the	_
20-11	3925-3932	scanner	_
20-12	3933-3936	and	_
20-13	3937-3946	completed	_
20-14	3947-3949	an	_
20-15	3950-3955	8-min	_
20-16	3956-3957	,	http://maven.renci.org/NeuroBridge/neurobridge#RestingStateImaging
20-17	3958-3962	eyes	http://maven.renci.org/NeuroBridge/neurobridge#RestingStateImaging
20-18	3963-3967	open	http://maven.renci.org/NeuroBridge/neurobridge#RestingStateImaging
20-19	3968-3975	resting	http://maven.renci.org/NeuroBridge/neurobridge#RestingStateImaging
20-20	3976-3980	scan	http://maven.renci.org/NeuroBridge/neurobridge#RestingStateImaging
20-21	3981-3983	at	_
20-22	3984-3989	onset	_
20-23	3990-3992	of	_
20-24	3993-3994	a	_
20-25	3995-4001	longer	_
20-26	4002-4006	scan	_
20-27	4007-4014	session	_
20-28	4015-4020	which	_
20-29	4021-4025	also	_
20-30	4026-4034	included	_
20-31	4035-4042	several	_
20-32	4043-4052	cognitive	_
20-33	4053-4058	tasks	_
20-34	4059-4060	(	_
20-35	4061-4064	see	_
20-36	4065-4066	)	_
20-37	4067-4068	.	_

21-1	4069-4070	(	_
21-2	4071-4074	See	_
21-3	4075-4085	supplement	_
21-4	4086-4089	for	_
21-5	4090-4093	MRI	_
21-6	4094-4098	data	_
21-7	4099-4110	acquisition	_
21-8	4111-4114	and	_
21-9	4115-4128	preprocessing	_
21-10	4129-4139	parameters	_
21-11	4140-4141	)	_
21-12	4142-4161	Abstinence-Specific	_
21-13	4162-4172	Procedures	_
21-14	4173-4177	Upon	_
21-15	4178-4188	completion	_
21-16	4189-4191	of	_
21-17	4192-4195	the	_
21-18	4196-4201	sated	_
21-19	4202-4206	scan	_
21-20	4207-4214	session	_
21-21	4215-4216	,	_
21-22	4217-4229	participants	_
21-23	4230-4235	began	_
21-24	4236-4242	weekly	_
21-25	4243-4251	meetings	_
21-26	4252-4256	with	_
21-27	4257-4258	a	_
21-28	4259-4268	cessation	_
21-29	4269-4278	counselor	_
21-30	4279-4282	who	_
21-31	4283-4284	,	_
21-32	4285-4293	together	_
21-33	4294-4298	with	_
21-34	4299-4302	the	_
21-35	4303-4314	participant	_
21-36	4315-4316	,	_
21-37	4317-4320	set	_
21-38	4321-4322	a	_
21-39	4323-4329	target	_
21-40	4330-4334	quit	_
21-41	4335-4339	date	_
21-42	4340-4343	and	_
21-43	4344-4348	time	_
21-44	4349-4352	for	_
21-45	4353-4363	completion	_
21-46	4364-4366	of	_
21-47	4367-4370	the	_
21-48	4371-4378	48-hour	_
21-49	4379-4389	abstinence	_
21-50	4390-4396	period	_
21-51	4397-4400	and	_
21-52	4401-4405	scan	_
21-53	4406-4413	session	_
21-54	4414-4415	.	_

22-1	4416-4420	DATA	_
22-2	4421-4429	ANALYSIS	http://maven.renci.org/NeuroBridge/neurobridge#CorrelationAnalysis
22-3	4430-4440	Behavioral	_
22-4	4441-4445	data	_
22-5	4446-4450	RVIP	_
22-6	4451-4455	task	_
22-7	4456-4467	performance	_
22-8	4468-4471	was	_
22-9	4472-4480	assessed	_
22-10	4481-4484	via	_
22-11	4485-4496	sensitivity	_
22-12	4497-4502	index	_
22-13	4503-4504	,	_
22-14	4505-4509	d′=Z	_
22-15	4510-4511	(	_
22-16	4512-4515	hit	_
22-17	4516-4520	rate	_
22-18	4521-4522	)	_
22-19	4523-4525	-Z	_
22-20	4526-4527	(	_
22-21	4528-4533	false	_
22-22	4534-4539	alarm	_
22-23	4540-4544	rate	_
22-24	4545-4546	)	_
22-25	4547-4548	.	_

23-1	4549-4556	SESSION	_
23-2	4557-4558	(	_
23-3	4559-4569	abstinence	_
23-4	4570-4571	(	_
23-5	4572-4573	−	_
23-6	4574-4575	)	_
23-7	4576-4581	sated	_
23-8	4582-4583	)	_
23-9	4584-4591	effects	_
23-10	4592-4596	were	_
23-11	4597-4607	calculated	_
23-12	4608-4611	via	_
23-13	4612-4618	paired	_
23-14	4619-4625	t-test	_
23-15	4626-4628	of	_
23-16	4629-4633	RVIP	_
23-17	4634-4636	d′	_
23-18	4637-4643	values	_
23-19	4644-4645	.	_

24-1	4646-4656	Subjective	_
24-2	4657-4664	Ratings	_
24-3	4665-4675	Withdrawal	_
24-4	4676-4679	was	_
24-5	4680-4688	assessed	_
24-6	4689-4692	via	_
24-7	4693-4697	WSWS	http://maven.renci.org/NeuroBridge/neurobridge#WisconsinSmokingWithdrawalScale
24-8	4698-4704	scores	_
24-9	4705-4708	for	_
24-10	4709-4713	each	_
24-11	4714-4722	scanning	_
24-12	4723-4730	session	_
24-13	4731-4732	.	_

25-1	4733-4740	SESSION	_
25-2	4741-4742	(	_
25-3	4743-4753	abstinence	_
25-4	4754-4755	(	_
25-5	4756-4757	−	_
25-6	4758-4759	)	_
25-7	4760-4765	sated	_
25-8	4766-4767	)	_
25-9	4768-4775	effects	_
25-10	4776-4780	were	_
25-11	4781-4791	calculated	_
25-12	4792-4795	via	_
25-13	4796-4802	paired	_
25-14	4803-4809	t-test	_
25-15	4810-4811	,	_
25-16	4812-4821	corrected	_
25-17	4822-4825	for	_
25-18	4826-4834	multiple	_
25-19	4835-4846	comparisons	_
25-20	4847-4852	based	_
25-21	4853-4855	on	_
25-22	4856-4859	the	_
25-23	4860-4861	7	_
25-24	4862-4871	subscales	_
25-25	4872-4875	and	_
25-26	4876-4881	total	_
25-27	4882-4887	score	_
25-28	4888-4896	assessed	_
25-29	4897-4898	(	_
25-30	4899-4910	p-corrected	_
25-31	4911-4912	<	_
25-32	4913-4919	0.05/8	_
25-33	4920-4921	=	_
25-34	4922-4929	0.00625	_
25-35	4930-4931	)	_
25-36	4932-4933	.	_

26-1	4934-4947	Resting-State	_
26-2	4948-4958	Functional	_
26-3	4959-4971	Connectivity	_
26-4	4972-4986	Single-subject	_
26-5	4987-4995	analysis	_
26-6	4996-4999	For	_
26-7	5000-5004	each	_
26-8	5005-5012	subject	_
26-9	5013-5014	,	_
26-10	5015-5026	correlation	_
26-11	5027-5038	coefficient	_
26-12	5039-5040	(	_
26-13	5041-5043	CC	_
26-14	5044-5045	)	_
26-15	5046-5052	images	_
26-16	5053-5057	were	_
26-17	5058-5066	computed	_
26-18	5067-5069	by	_
26-19	5070-5081	correlating	_
26-20	5082-5086	each	_
26-21	5087-5092	voxel	_
26-22	5093-5094	’	_
26-23	5095-5096	s	_
26-24	5097-5112	motion-censored	_
26-25	5113-5117	time	_
26-26	5118-5124	course	_
26-27	5125-5129	with	_
26-28	5130-5131	a	_
26-29	5132-5141	reference	_
26-30	5142-5146	time	_
26-31	5147-5153	course	_
26-32	5154-5158	from	_
26-33	5159-5162	the	_
26-34	5163-5164	3	_
26-35	5165-5170	right	_
26-36	5171-5177	insula	_
26-37	5178-5183	seeds	_
26-38	5184-5185	(	_
26-39	5186-5192	Dorsal	_
26-40	5193-5194	(	_
26-41	5195-5198	DOR	_
26-42	5199-5200	)	_
26-43	5201-5202	,	_
26-44	5203-5210	Ventral	_
26-45	5211-5212	(	_
26-46	5213-5216	VEN	_
26-47	5217-5218	)	_
26-48	5219-5220	,	_
26-49	5221-5224	and	_
26-50	5225-5234	Posterior	_
26-51	5235-5236	(	_
26-52	5237-5240	POS	_
26-53	5241-5242	)	_
26-54	5243-5244	)	_
26-55	5245-5252	defined	_
26-56	5253-5256	via	_
26-57	5257-5270	probabilistic	_
26-58	5271-5276	voxel	_
26-59	5277-5281	maps	_
26-60	5282-5289	created	_
26-61	5290-5292	by	_
26-62	5293-5298	Chang	_
26-63	5299-5301	et	_
26-64	5302-5304	al	_
26-65	5305-5307	..	_
26-66	5308-5311	Any	_
26-67	5312-5317	voxel	_
26-68	5318-5322	with	_
26-69	5323-5324	>	_
26-70	5325-5327	85	_
26-71	5328-5329	%	_
26-72	5330-5339	inclusion	_
26-73	5340-5351	probability	_
26-74	5352-5354	in	_
26-75	5355-5359	each	_
26-76	5360-5367	insular	_
26-77	5368-5379	subdivision	_
26-78	5380-5383	was	_
26-79	5384-5392	included	_
26-80	5393-5395	in	_
26-81	5396-5399	the	_
26-82	5400-5404	mask	_
26-83	5405-5408	for	_
26-84	5409-5413	that	_
26-85	5414-5425	subdivision	_
26-86	5426-5427	,	_
26-87	5428-5437	resulting	_
26-88	5438-5440	in	_
26-89	5441-5446	three	_
26-90	5447-5462	non-overlapping	_
26-91	5463-5470	insular	_
26-92	5471-5482	subdivision	_
26-93	5483-5488	seeds	_
26-94	5489-5490	.	_

27-1	5491-5492	(	_
27-2	5493-5496	Fig	_
27-3	5497-5498	1	_
27-4	5499-5500	,	_
27-5	5501-5506	Table	_
27-6	5507-5509	S1	_
27-7	5510-5511	)	_
27-8	5512-5515	The	_
27-9	5516-5525	resulting	_
27-10	5526-5539	subject-level	_
27-11	5540-5542	CC	_
27-12	5543-5549	images	_
27-13	5550-5554	were	_
27-14	5555-5561	Fisher	_
27-15	5562-5563	’	_
27-16	5564-5565	s	_
27-17	5566-5579	Z-transformed	_
27-18	5580-5581	(	_
27-19	5582-5583	)	_
27-20	5584-5586	to	_
27-21	5587-5593	better	_
27-22	5594-5605	approximate	_
27-23	5606-5607	a	_
27-24	5608-5614	normal	_
27-25	5615-5627	distribution	_
27-26	5628-5629	.	_

28-1	5630-5632	In	_
28-2	5633-5641	addition	_
28-3	5642-5643	,	_
28-4	5644-5646	as	_
28-5	5647-5648	a	_
28-6	5649-5653	post	_
28-7	5654-5657	hoc	_
28-8	5658-5662	test	_
28-9	5663-5666	for	_
28-10	5667-5676	potential	_
28-11	5677-5688	hemispheric	_
28-12	5689-5700	differences	_
28-13	5701-5702	,	_
28-14	5703-5708	right	_
28-15	5709-5715	insula	_
28-16	5716-5720	seed	_
28-17	5721-5726	masks	_
28-18	5727-5731	were	_
28-19	5732-5741	reflected	_
28-20	5742-5748	across	_
28-21	5749-5752	the	_
28-22	5753-5760	midline	_
28-23	5761-5763	to	_
28-24	5764-5768	left	_
28-25	5769-5775	insula	_
28-26	5776-5777	(	_
28-27	5778-5781	Fig	_
28-28	5782-5785	S2a	_
28-29	5786-5787	)	_
28-30	5788-5791	and	_
28-31	5792-5799	similar	_
28-32	5800-5813	subject-level	_
28-33	5814-5816	CC	_
28-34	5817-5823	images	_
28-35	5824-5828	were	_
28-36	5829-5837	computed	_
28-37	5838-5839	.	_

29-1	5840-5844	rsFC	_
29-2	5845-5851	target	_
29-3	5852-5859	network	_
29-4	5860-5874	identification	_
29-5	5875-5879	Seed	_
29-6	5880-5885	based	_
29-7	5886-5894	analyses	_
29-8	5895-5899	were	_
29-9	5900-5901	a	_
29-10	5902-5908	priori	_
29-11	5909-5920	constrained	_
29-12	5921-5923	to	_
29-13	5924-5930	voxels	_
29-14	5931-5937	within	_
29-15	5938-5942	each	_
29-16	5943-5945	of	_
29-17	5946-5949	the	_
29-18	5950-5955	three	_
29-19	5956-5968	functionally	_
29-20	5969-5978	generated	_
29-21	5979-5984	masks	_
29-22	5985-5987	of	_
29-23	5988-5999	large-scale	_
29-24	6000-6005	brain	_
29-25	6006-6014	networks	_
29-26	6015-6027	consistently	_
29-27	6028-6033	shown	_
29-28	6034-6042	relevant	_
29-29	6043-6045	to	_
29-30	6046-6054	nicotine	_
29-31	6055-6064	addiction	_
29-32	6065-6066	:	_
29-33	6067-6070	DMN	_
29-34	6071-6072	,	_
29-35	6073-6076	ECN	_
29-36	6077-6078	,	_
29-37	6079-6082	and	_
29-38	6083-6085	SN	_
29-39	6086-6087	.	_

30-1	6088-6093	These	_
30-2	6094-6099	brain	_
30-3	6100-6107	network	_
30-4	6108-6113	masks	_
30-5	6114-6118	were	_
30-6	6119-6129	identified	_
30-7	6130-6133	via	_
30-8	6134-6145	group-level	_
30-9	6146-6157	independent	_
30-10	6158-6167	component	_
30-11	6168-6176	analysis	_
30-12	6177-6178	(	_
30-13	6179-6183	gICA	_
30-14	6184-6185	)	_
30-15	6186-6187	,	_
30-16	6188-6197	resulting	_
30-17	6198-6200	in	_
30-18	6201-6206	voxel	_
30-19	6207-6212	masks	_
30-20	6213-6216	for	_
30-21	6217-6221	each	_
30-22	6222-6229	network	_
30-23	6230-6231	(	_
30-24	6232-6235	Fig	_
30-25	6236-6237	1	_
30-26	6238-6239	,	_
30-27	6240-6243	See	_
30-28	6244-6256	Supplemental	_
30-29	6257-6266	materials	_
30-30	6267-6270	for	_
30-31	6271-6275	gICA	_
30-32	6276-6282	method	_
30-33	6283-6290	details	_
30-34	6291-6292	)	_
30-35	6293-6294	.	_

31-1	6295-6298	For	_
31-2	6299-6303	each	_
31-3	6304-6319	gICA-identified	_
31-4	6320-6327	network	_
31-5	6328-6329	,	_
31-6	6330-6332	an	_
31-7	6333-6343	individual	_
31-8	6344-6348	mask	_
31-9	6349-6351	of	_
31-10	6352-6361	resultant	_
31-11	6362-6368	voxels	_
31-12	6369-6370	(	_
31-13	6371-6374	Fig	_
31-14	6375-6376	1	_
31-15	6377-6378	)	_
31-16	6379-6382	was	_
31-17	6383-6387	used	_
31-18	6388-6390	in	_
31-19	6391-6397	s-rsFC	_
31-20	6398-6401	and	_
31-21	6402-6408	d-rsFC	_
31-22	6409-6417	analyses	_
31-23	6418-6419	.	_

32-1	6420-6426	Static	_
32-2	6427-6431	rsFC	_
32-3	6432-6440	analysis	_
32-4	6441-6447	Paired	_
32-5	6448-6455	t-tests	_
32-6	6456-6458	of	_
32-7	6459-6466	SESSION	_
32-8	6467-6477	difference	_
32-9	6478-6480	in	_
32-10	6481-6487	s-rsFC	_
32-11	6488-6496	strength	_
32-12	6497-6504	between	_
32-13	6505-6509	each	_
32-14	6510-6512	of	_
32-15	6513-6516	the	_
32-16	6517-6518	3	_
32-17	6519-6526	insular	_
32-18	6527-6532	seeds	_
32-19	6533-6536	and	_
32-20	6537-6543	voxels	_
32-21	6544-6550	within	_
32-22	6551-6555	each	_
32-23	6556-6558	of	_
32-24	6559-6562	the	_
32-25	6563-6564	3	_
32-26	6565-6576	large-scale	_
32-27	6577-6584	network	_
32-28	6585-6590	masks	_
32-29	6591-6595	were	_
32-30	6596-6605	performed	_
32-31	6606-6607	(	_
32-32	6608-6611	i.e	_
32-33	6612-6613	.	_

33-1	6614-6622	seed-ECN	_
33-2	6623-6629	voxels	_
33-3	6630-6631	;	_
33-4	6632-6639	seed-SN	_
33-5	6640-6646	voxels	_
33-6	6647-6648	;	_
33-7	6649-6657	seed-DMN	_
33-8	6658-6664	voxels	_
33-9	6665-6666	)	_
33-10	6667-6671	with	_
33-11	6672-6682	correction	_
33-12	6683-6686	for	_
33-13	6687-6695	multiple	_
33-14	6696-6707	comparisons	_
33-15	6708-6709	(	_
33-16	6710-6711	3	_
33-17	6712-6717	seeds	_
33-18	6718-6719	*	_
33-19	6720-6721	3	_
33-20	6722-6728	target	_
33-21	6729-6737	networks	_
33-22	6738-6739	,	_
33-23	6740-6741	1	_
33-24	6742-6747	sided	_
33-25	6748-6753	tests	_
33-26	6754-6757	for	_
33-27	6758-6761	DMN	_
33-28	6762-6765	and	_
33-29	6766-6769	ECN	_
33-30	6770-6774	rsFC	_
33-31	6775-6776	,	_
33-32	6777-6778	2	_
33-33	6779-6784	sided	_
33-34	6785-6790	tests	_
33-35	6791-6794	for	_
33-36	6795-6797	SN	_
33-37	6798-6802	rsFC	_
33-38	6803-6804	)	_
33-39	6805-6808	and	_
33-40	6809-6827	cluster-correction	_
33-41	6828-6835	applied	_
33-42	6836-6837	(	_
33-43	6838-6845	p-voxel	_
33-44	6846-6847	<	_
33-45	6848-6854	0.0167	_
33-46	6855-6856	,	_
33-47	6857-6868	p-corrected	_
33-48	6869-6870	<	_
33-49	6871-6877	0.05/9	_
33-50	6878-6879	=	_
33-51	6880-6886	0.0056	_
33-52	6887-6890	for	_
33-53	6891-6895	each	_
33-54	6896-6900	test	_
33-55	6901-6902	)	_
33-56	6903-6904	.	_

34-1	6905-6909	Post	_
34-2	6910-6913	hoc	_
34-3	6914-6919	tests	_
34-4	6920-6923	for	_
34-5	6924-6935	hemispheric	_
34-6	6936-6947	differences	_
34-7	6948-6957	employing	_
34-8	6958-6962	left	_
34-9	6963-6969	insula	_
34-10	6970-6975	seeds	_
34-11	6976-6980	were	_
34-12	6981-6990	conducted	_
34-13	6991-6995	with	_
34-14	6996-7005	identical	_
34-15	7006-7017	statistical	_
34-16	7018-7029	corrections	_
34-17	7030-7031	(	_
34-18	7032-7039	p-voxel	_
34-19	7040-7041	<	_
34-20	7042-7048	0.0167	_
34-21	7049-7050	,	_
34-22	7051-7062	p-corrected	_
34-23	7063-7064	<	_
34-24	7065-7071	0.0056	_
34-25	7072-7073	)	_
34-26	7074-7075	.	_

35-1	7076-7083	Dynamic	_
35-2	7084-7088	rsFC	_
35-3	7089-7097	analysis	_
35-4	7098-7101	The	_
35-5	7102-7107	three	_
35-6	7108-7113	right	_
35-7	7114-7121	insular	_
35-8	7122-7127	seeds	_
35-9	7128-7129	(	_
35-10	7130-7133	DOR	_
35-11	7134-7135	,	_
35-12	7136-7139	VEN	_
35-13	7140-7141	,	_
35-14	7142-7145	POS	_
35-15	7146-7147	)	_
35-16	7148-7151	and	_
35-17	7152-7155	the	_
35-18	7156-7161	three	_
35-19	7162-7167	brain	_
35-20	7168-7175	network	_
35-21	7176-7181	masks	_
35-22	7182-7183	(	_
35-23	7184-7187	ECN	_
35-24	7188-7189	,	_
35-25	7190-7193	DMN	_
35-26	7194-7195	,	_
35-27	7196-7198	SN	_
35-28	7199-7200	)	_
35-29	7201-7205	were	_
35-30	7206-7215	resampled	_
35-31	7216-7218	to	_
35-32	7219-7224	4×4×4	_
35-33	7225-7227	mm	_
35-34	7228-7233	voxel	_
35-35	7234-7238	size	_
35-36	7239-7241	to	_
35-37	7242-7248	reduce	_
35-38	7249-7262	computational	_
35-39	7263-7267	load	_
35-40	7268-7269	.	_

36-1	7270-7274	Mean	_
36-2	7275-7279	time	_
36-3	7280-7286	series	_
36-4	7287-7291	from	_
36-5	7292-7299	insular	_
36-6	7300-7305	seeds	_
36-7	7306-7310	were	_
36-8	7311-7320	extracted	_
36-9	7321-7324	and	_
36-10	7325-7329	used	_
36-11	7330-7332	as	_
36-12	7333-7337	seed	_
36-13	7338-7342	time	_
36-14	7343-7350	courses	_
36-15	7351-7352	.	_

37-1	7353-7359	D-rsFC	_
37-2	7360-7367	between	_
37-3	7368-7371	the	_
37-4	7372-7373	3	_
37-5	7374-7380	insula	_
37-6	7381-7386	seeds	_
37-7	7387-7390	and	_
37-8	7391-7392	3	_
37-9	7393-7398	brain	_
37-10	7399-7406	network	_
37-11	7407-7414	targets	_
37-12	7415-7419	were	_
37-13	7420-7429	estimated	_
37-14	7430-7435	using	_
37-15	7436-7437	a	_
37-16	7438-7445	sliding	_
37-17	7446-7452	window	_
37-18	7453-7459	method	_
37-19	7460-7461	.	_

38-1	7462-7464	By	_
38-2	7465-7472	sliding	_
38-3	7473-7474	a	_
38-4	7475-7482	Hamming	_
38-5	7483-7489	window	_
38-6	7490-7494	with	_
38-7	7495-7501	window	_
38-8	7502-7507	width	_
38-9	7508-7510	of	_
38-10	7511-7513	22	_
38-11	7514-7517	TRs	_
38-12	7518-7519	(	_
38-13	7520-7522	44	_
38-14	7523-7527	secs	_
38-15	7528-7529	)	_
38-16	7530-7533	and	_
38-17	7534-7541	sliding	_
38-18	7542-7547	steps	_
38-19	7548-7550	of	_
38-20	7551-7552	1	_
38-21	7553-7555	TR	_
38-22	7556-7557	,	_
38-23	7558-7569	correlation	_
38-24	7570-7578	matrices	_
38-25	7579-7586	between	_
38-26	7587-7591	each	_
38-27	7592-7598	insula	_
38-28	7599-7603	seed	_
38-29	7604-7608	time	_
38-30	7609-7615	course	_
38-31	7616-7619	and	_
38-32	7620-7623	the	_
38-33	7624-7628	time	_
38-34	7629-7635	series	_
38-35	7636-7638	of	_
38-36	7639-7643	each	_
38-37	7644-7649	voxel	_
38-38	7650-7652	in	_
38-39	7653-7657	each	_
38-40	7658-7660	of	_
38-41	7661-7664	the	_
38-42	7665-7666	3	_
38-43	7667-7672	brain	_
38-44	7673-7680	network	_
38-45	7681-7686	masks	_
38-46	7687-7693	within	_
38-47	7694-7698	each	_
38-48	7699-7703	time	_
38-49	7704-7710	window	_
38-50	7711-7715	were	_
38-51	7716-7724	computed	_
38-52	7725-7726	.	_

39-1	7727-7732	These	_
39-2	7733-7741	windowed	_
39-3	7742-7753	correlation	_
39-4	7754-7762	matrices	_
39-5	7763-7767	were	_
39-6	7768-7772	then	_
39-7	7773-7784	transformed	_
39-8	7785-7790	using	_
39-9	7791-7797	Fisher	_
39-10	7798-7799	’	_
39-11	7800-7801	s	_
39-12	7802-7818	Z-transformation	_
39-13	7819-7822	and	_
39-14	7823-7835	concatenated	_
39-15	7836-7838	to	_
39-16	7839-7843	form	_
39-17	7844-7845	a	_
39-18	7846-7848	3D	_
39-19	7849-7855	matrix	_
39-20	7856-7857	,	_
39-21	7858-7863	sized	_
39-22	7864-7874	3×5510×209	_
39-23	7875-7878	for	_
39-24	7879-7883	each	_
39-25	7884-7891	subject	_
39-26	7892-7895	and	_
39-27	7896-7903	session	_
39-28	7904-7905	.	_

40-1	7906-7908	To	_
40-2	7909-7915	assess	_
40-3	7916-7919	the	_
40-4	7920-7929	structure	_
40-5	7930-7932	of	_
40-6	7933-7944	reoccurring	_
40-7	7945-7957	connectivity	_
40-8	7958-7966	patterns	_
40-9	7967-7968	,	_
40-10	7969-7976	k-means	_
40-11	7977-7987	clustering	_
40-12	7988-7997	algorithm	_
40-13	7998-8001	was	_
40-14	8002-8009	applied	_
40-15	8010-8012	to	_
40-16	8013-8021	windowed	_
40-17	8022-8033	correlation	_
40-18	8034-8042	matrices	_
40-19	8043-8046	and	_
40-20	8047-8055	repeated	_
40-21	8056-8059	500	_
40-22	8060-8065	times	_
40-23	8066-8070	with	_
40-24	8071-8077	random	_
40-25	8078-8092	initialization	_
40-26	8093-8095	of	_
40-27	8096-8104	centroid	_
40-28	8105-8114	positions	_
40-29	8115-8117	to	_
40-30	8118-8123	avoid	_
40-31	8124-8134	converging	_
40-32	8135-8139	into	_
40-33	8140-8145	local	_
40-34	8146-8152	minima	_
40-35	8153-8154	.	_

41-1	8155-8158	The	_
41-2	8159-8168	resulting	_
41-3	8169-8177	centroid	_
41-4	8178-8180	of	_
41-5	8181-8185	each	_
41-6	8186-8193	cluster	_
41-7	8194-8195	(	_
41-8	8196-8199	n=6	_
41-9	8200-8205	based	_
41-10	8206-8208	on	_
41-11	8209-8212	the	_
41-12	8213-8223	silhouette	_
41-13	8224-8233	criterion	_
41-14	8234-8235	;	_
41-15	8236-8239	Fig	_
41-16	8240-8242	S1	_
41-17	8243-8244	)	_
41-18	8245-8248	was	_
41-19	8249-8259	recognized	_
41-20	8260-8262	as	_
41-21	8263-8264	a	_
41-22	8265-8270	state	_
41-23	8271-8272	.	_

42-1	8273-8278	After	_
42-2	8279-8289	clustering	_
42-3	8290-8291	,	_
42-4	8292-8296	each	_
42-5	8297-8305	windowed	_
42-6	8306-8317	correlation	_
42-7	8318-8324	matrix	_
42-8	8325-8328	was	_
42-9	8329-8337	assigned	_
42-10	8338-8340	to	_
42-11	8341-8344	one	_
42-12	8345-8347	of	_
42-13	8348-8351	the	_
42-14	8352-8353	6	_
42-15	8354-8364	identified	_
42-16	8365-8371	states	_
42-17	8372-8373	.	_

43-1	8374-8377	For	_
43-2	8378-8382	each	_
43-3	8383-8390	subject	_
43-4	8391-8393	in	_
43-5	8394-8398	each	_
43-6	8399-8406	session	_
43-7	8407-8408	,	_
43-8	8409-8410	a	_
43-9	8411-8416	state	_
43-10	8417-8427	transition	_
43-11	8428-8435	process	_
43-12	8436-8439	was	_
43-13	8440-8449	described	_
43-14	8450-8455	using	_
43-15	8456-8457	a	_
43-16	8458-8464	Markov	_
43-17	8465-8471	matrix	_
43-18	8472-8473	.	_

44-1	8474-8481	SESSION	_
44-2	8482-8489	effects	_
44-3	8490-8494	were	_
44-4	8495-8503	assessed	_
44-5	8504-8507	via	_
44-6	8508-8509	a	_
44-7	8510-8516	paired	_
44-8	8517-8523	t-test	_
44-9	8524-8525	(	_
44-10	8526-8527	P	_
44-11	8528-8529	(	_
44-12	8530-8536	remain	_
44-13	8537-8539	in	_
44-14	8540-8547	current	_
44-15	8548-8553	state	_
44-16	8554-8555	)	_
44-17	8556-8557	)	_
44-18	8558-8566	—defined	_
44-19	8567-8569	as	_
44-20	8570-8573	sum	_
44-21	8574-8576	of	_
44-22	8577-8580	the	_
44-23	8581-8589	diagonal	_
44-24	8590-8592	of	_
44-25	8593-8596	the	_
44-26	8597-8603	Markov	_
44-27	8604-8610	matrix	_
44-28	8611-8612	.	_

45-1	8613-8624	Correlation	_
45-2	8625-8633	analyses	_
45-3	8634-8642	Measures	_
45-4	8643-8645	of	_
45-5	8646-8652	static	_
45-6	8653-8656	and	_
45-7	8657-8664	dynamic	_
45-8	8665-8669	rsFC	_
45-9	8670-8677	showing	_
45-10	8678-8679	a	_
45-11	8680-8691	significant	_
45-12	8692-8699	SESSION	_
45-13	8700-8706	effect	_
45-14	8707-8711	were	_
45-15	8712-8721	extracted	_
45-16	8722-8725	for	_
45-17	8726-8730	both	_
45-18	8731-8734	the	_
45-19	8735-8744	abstinent	_
45-20	8745-8748	and	_
45-21	8749-8754	sated	_
45-22	8755-8765	conditions	_
45-23	8766-8769	for	_
45-24	8770-8774	each	_
45-25	8775-8786	participant	_
45-26	8787-8788	,	_
45-27	8789-8793	with	_
45-28	8794-8797	the	_
45-29	8798-8807	magnitude	_
45-30	8808-8810	of	_
45-31	8811-8815	rsFC	_
45-32	8816-8823	SESSION	_
45-33	8824-8830	effect	_
45-34	8831-8841	correlated	_
45-35	8842-8846	with	_
45-36	8847-8850	the	_
45-37	8851-8860	magnitude	_
45-38	8861-8863	of	_
45-39	8864-8871	SESSION	_
45-40	8872-8879	effects	_
45-41	8880-8882	on	_
45-42	8883-8887	both	_
45-43	8888-8892	RVIP	_
45-44	8893-8895	d′	_
45-45	8896-8899	and	_
45-46	8900-8904	WSWS	_
45-47	8905-8913	subscale	_
45-48	8914-8924	subjective	_
45-49	8925-8932	ratings	_
45-50	8933-8934	.	_

46-1	8935-8940	These	_
46-2	8941-8953	correlations	_
46-3	8954-8958	were	_
46-4	8959-8968	corrected	_
46-5	8969-8972	for	_
46-6	8973-8981	multiple	_
46-7	8982-8993	comparisons	_
46-8	8994-8999	based	_
46-9	9000-9002	on	_
46-10	9003-9006	the	_
46-11	9007-9013	number	_
46-12	9014-9016	of	_
46-13	9017-9021	rsFC	_
46-14	9022-9030	measures	_
46-15	9031-9037	tested	_
46-16	9038-9039	(	_
46-17	9040-9043	n=5	_
46-18	9044-9045	:	_
46-19	9046-9047	4	_
46-20	9048-9054	s-rsFC	_
46-21	9055-9063	circuits	_
46-22	9064-9074	identified	_
46-23	9075-9076	,	_
46-24	9077-9078	1	_
46-25	9079-9085	d-rsFC	_
46-26	9086-9093	measure	_
46-27	9094-9095	)	_
46-28	9096-9097	*	_
46-29	9098-9103	state	_
46-30	9104-9112	measures	_
46-31	9113-9119	tested	_
46-32	9120-9121	(	_
46-33	9122-9125	n=6	_
46-34	9126-9127	:	_
46-35	9128-9132	RVIP	_
46-36	9133-9135	d′	_
46-37	9136-9137	,	_
46-38	9138-9142	WSWS	_
46-39	9143-9152	subscales	_
46-40	9153-9154	)	_
46-41	9155-9156	(	_
46-42	9157-9168	p-corrected	_
46-43	9169-9170	<	_
46-44	9171-9178	0.05/30	_
46-45	9179-9180	=	_
46-46	9181-9188	0.00167	_
46-47	9189-9190	)	_
46-48	9191-9192	.	_

47-1	9193-9200	Finally	_
47-2	9201-9202	,	_
47-3	9203-9207	post	_
47-4	9208-9211	hoc	_
47-5	9212-9224	correlations	_
47-6	9225-9232	between	_
47-7	9233-9237	rsFC	_
47-8	9238-9246	measures	_
47-9	9247-9250	and	_
47-10	9251-9260	cognitive	_
47-11	9261-9264	and	_
47-12	9265-9275	subjective	_
47-13	9276-9286	withdrawal	_
47-14	9287-9295	measures	_
47-15	9296-9300	were	_
47-16	9301-9311	calculated	_
47-17	9312-9314	at	_
47-18	9315-9319	both	_
47-19	9320-9330	abstinence	_
47-20	9331-9334	and	_
47-21	9335-9342	satiety	_
47-22	9343-9355	individually	_
47-23	9356-9357	.	_

48-1	9358-9360	In	_
48-2	9361-9365	each	_
48-3	9366-9370	case	_
48-4	9371-9372	,	_
48-5	9373-9387	state-specific	_
48-6	9388-9400	correlations	_
48-7	9401-9405	were	_
48-8	9406-9410	only	_
48-9	9411-9420	evaluated	_
48-10	9421-9424	for	_
48-11	9425-9430	those	_
48-12	9431-9445	insular-seeded	_
48-13	9446-9450	rsFC	_
48-14	9451-9459	circuits	_
48-15	9460-9464	that	_
48-16	9465-9471	showed	_
48-17	9472-9473	a	_
48-18	9474-9481	SESSION	_
48-19	9482-9488	effect	_
48-20	9489-9490	.	_

49-1	9491-9493	As	_
49-2	9494-9499	above	_
49-3	9500-9501	,	_
49-4	9502-9507	these	_
49-5	9508-9517	follow-up	_
49-6	9518-9523	tests	_
49-7	9524-9528	were	_
49-8	9529-9538	corrected	_
49-9	9539-9542	for	_
49-10	9543-9551	multiple	_
49-11	9552-9563	comparisons	_
49-12	9564-9569	based	_
49-13	9570-9572	on	_
49-14	9573-9576	the	_
49-15	9577-9583	number	_
49-16	9584-9586	of	_
49-17	9587-9591	rsFC	_
49-18	9592-9600	measures	_
49-19	9601-9602	(	_
49-20	9603-9606	n=5	_
49-21	9607-9608	)	_
49-22	9609-9610	,	_
49-23	9611-9621	subjective	_
49-24	9622-9630	measures	_
49-25	9631-9632	(	_
49-26	9633-9636	n=6	_
49-27	9637-9638	)	_
49-28	9639-9640	,	_
49-29	9641-9644	and	_
49-30	9645-9651	states	_
49-31	9652-9653	(	_
49-32	9654-9657	n=2	_
49-33	9658-9659	)	_
49-34	9660-9666	tested	_
49-35	9667-9668	(	_
49-36	9669-9680	p-corrected	_
49-37	9681-9682	<	_
49-38	9683-9690	0.05/60	_
49-39	9691-9692	=	_
49-40	9693-9700	0.00083	_
49-41	9701-9702	)	_
49-42	9703-9704	.	_

